LANTERN PHARMA Trademark

Trademark Overview


On Wednesday, September 11, 2019, a trademark application was filed for LANTERN PHARMA with the United States Patent and Trademark Office. The USPTO has given the LANTERN PHARMA trademark a serial number of 88612435. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Thursday, September 18, 2025. This trademark is owned by Lantern Pharma Inc.. The LANTERN PHARMA trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

drug discovery services; pharmaceutical research and development services in the field of oncology; pharmaceutical drug discovery services in the field of oncology; scientific and medical research and development for pharmaceuticals, pharmaceutical preparations and substances in the field of oncology
lantern pharma

General Information


Serial Number88612435
Word MarkLANTERN PHARMA
Filing DateWednesday, September 11, 2019
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateThursday, September 18, 2025
Registration Number5973379
Registration DateTuesday, January 28, 2020
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 12, 2019

Trademark Statements


NOT AVAILABLE"PHARMA"
Goods and Servicesdrug discovery services; pharmaceutical research and development services in the field of oncology; pharmaceutical drug discovery services in the field of oncology; scientific and medical research and development for pharmaceuticals, pharmaceutical preparations and substances in the field of oncology

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, September 20, 2019
Primary Code042
First Use Anywhere DateSunday, January 1, 2017
First Use In Commerce DateSunday, January 1, 2017

Trademark Owner History


Party NameLANTERN PHARMA INC
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressDALLAS, TX 75201

Party NameLantern Pharma Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressDallas, TX 75201

Party NameLantern Pharma Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDallas, TX 75201

Party NameLantern Pharma Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDallas, TX 75201

Trademark Events


Event DateEvent Description
Friday, September 27, 2019EXAMINERS AMENDMENT -WRITTEN
Friday, September 27, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Saturday, September 14, 2019NEW APPLICATION ENTERED
Friday, September 20, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, September 26, 2019ASSIGNED TO EXAMINER
Friday, September 27, 2019EXAMINERS AMENDMENT E-MAILED
Friday, September 27, 2019EXAMINER'S AMENDMENT ENTERED
Friday, September 27, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 23, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, May 20, 2020AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Friday, January 15, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, October 4, 2019ASSIGNED TO LIE
Tuesday, November 12, 2019PUBLISHED FOR OPPOSITION
Tuesday, November 12, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 28, 2020REGISTERED-PRINCIPAL REGISTER
Friday, January 15, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, January 15, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, January 15, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, January 15, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, January 28, 2025COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, May 7, 2025TEAS SECTION 8 & 15 RECEIVED
Thursday, September 18, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, September 18, 2025REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Thursday, September 18, 2025NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED